• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Long ‐term follow‐up after PFO device closure
ConclusionsDevice closure of PFO can be performed safely with very good long‐term resolution of atrial shunting. Recurrent neurologic events after PFO closure may reflect additional comorbid risk factors unrelated to the potential for paradoxical embolism. © 2016 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - March 28, 2016 Category: Cardiovascular & Thoracic Surgery Authors: Nathaniel W. Taggart, Guy S. Reeder, Ryan J. Lennon, Joshua P. Slusser, Monique A. Freund, Allison K. Cabalka, Frank Cetta, Donald J. Hagler Tags: Valvular and Structural Heart Diseases Source Type: research

Percutaneous patent foramen ovale closure using the Occlutech Figulla device: More than 1,300 patient ‐years of follow up
ConclusionThe Occlutech device appears to be safe at long ‐term FU with a very low annual cerebrovascular event rate and a low moderate to large shunt rate at 1‐year FU.
Source: Catheterization and Cardiovascular Interventions - November 20, 2018 Category: Cardiovascular & Thoracic Surgery Authors: Roel J. R. Snijder, Laura E. Renes, Maarten Jan Suttorp, Jurrien M. ten Berg, Martijn C. Post Tags: VALVULAR AND STRUCTURAL HEART DISEASES Source Type: research

Interventional closure of patent foramen ovale with Nit ‐occlud® device in prevention of recurrent neurologic events—Long‐term results
ConclusionsThe Nit‐Occlud PFO device and its delivery system are safe and provides sufficient closure of PFO in patients who suffered from cryptogenic stroke, TIA or paradoxical peripheral embolism. It is associated with high procedural success and favorable rates of complete closure.
Source: Catheterization and Cardiovascular Interventions - October 25, 2017 Category: Cardiovascular & Thoracic Surgery Authors: Aleksander Araszkiewicz, Sylwia S ławek, Olga Trojnarska, Maciej Lesiak, Marek Grygier Tags: VALVULAR AND STRUCTURAL HEART DISEASES Source Type: research

Long-term effectiveness and safety of transcatheter closure of patent foramen ovale compared with antithrombotic therapy: A meta-analysis of 6 randomised clinical trials and 3560 patients with reconstructed time-to-event data.
CONCLUSIONS: Compared with ATA, tPFOc reduces the risk of stroke at long-term follow-up but no benefit is observed in terms of TIA. Atrial fibrillation is higher after tPFOc, while major bleeding and migraine are comparable between groups. PMID: 29901447 [PubMed - as supplied by publisher]
Source: EuroIntervention - June 15, 2018 Category: Cardiovascular & Thoracic Surgery Tags: EuroIntervention Source Type: research

A meta‐analysis of transcatheter closure of patent foramen ovale versus medical therapy for prevention of recurrent thromboembolic events in patients with cryptogenic cerebrovascular events
ConclusionIn this meta‐analysis of contemporary RCTs, successful transcatheter closure of PFO might be more effective than medical therapy alone for the prevention of recurrent thromboembolic events. © 2013 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - July 5, 2013 Category: Cardiovascular & Thoracic Surgery Authors: Andrés M. Pineda, Francisco O. Nascimento, Solomon Yang, Ajay Kirtane, Robert Sommer, Nirat Beohar Tags: Original Studies Source Type: research

Results of percutaneous closure of patent foramen ovale with the GORE ® Septal Occluder
Conclusion. PFO closure with the GSO is accompanied by a high technical success rate and closure rates similar to other currently used devices. The incidence of atrial fibrillation was higher than reported with most other devices. This may be a chance finding but warrants further investigation in larger trials. © 2013 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - December 10, 2013 Category: Cardiovascular & Thoracic Surgery Authors: Meike Knerr, Stefan Bertog, Laura Vaskelyte, Ilona Hofmann, Horst Sievert Tags: Original Study Source Type: research

Results of percutaneous closure of patent foramen ovale with the GORE® septal occluder
ConclusionPFO closure with the GSO is accompanied by a high technical success rate and closure rates similar to other currently used devices. The incidence of AF was higher than reported with most other devices. This may be a chance finding but warrants further investigation in larger trials. © 2013 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - January 20, 2014 Category: Cardiovascular & Thoracic Surgery Authors: Meike Knerr, Stefan Bertog, Laura Vaskelyte, Ilona Hofmann, Horst Sievert Tags: Valvular and Structural Heart Diseases Source Type: research

089 * innominate artery cannulation for proximal aortic surgery: outcomes and neurologic events in 263 patients
Conclusion: Innominate artery cannulation can be performed safely and poses a low risk of neurologic events in procedures requiring hypothermic circulatory arrest. This artery may be considered the optimal perfusion site for delivering ACP.
Source: Interactive CardioVascular and Thoracic Surgery - September 23, 2014 Category: Cardiovascular & Thoracic Surgery Authors: Preventza, O., Garcia, A., Tuluca, A., Henry, M., Bakaeen, F., Omer, S., Cornwell, L., Coselli, J. S. Tags: Part II: Cannulation issues in aortic surgery: Doing things right or doing the right things Source Type: research

Efficacy of different devices for transcatheter closure of patent foramen ovale assessed by serial transoesophageal echocardiography and rates of recurrent cerebrovascular events in a long-term follow-up.
Conclusions: Closure at three or 12 months (as measured by cTEE) and rates of recurrent cerebrovascular events were similar among occluder groups. PFO diameter was a risk factor for residual shunting, but not the presence of ASA. The rate of recurrent cerebral ischaemic events was low. PMID: 25572024 [PubMed - as supplied by publisher]
Source: EuroIntervention - January 15, 2015 Category: Cardiovascular & Thoracic Surgery Tags: EuroIntervention Source Type: research

Innominate artery cannulation for proximal aortic surgery: outcomes and neurological events in 263 patients AORTIC SURGERY
CONCLUSIONS Innominate artery cannulation can be performed safely and poses a low risk of neurological events in procedures requiring hypothermic circulatory arrest. The technique for cannulating this artery should be part of the routine armamentarium of cardiac and aortic surgeons, and the innominate artery is among the preferred perfusion sites for delivering ACP.
Source: European Journal of Cardio-Thoracic Surgery - November 17, 2015 Category: Cardiovascular & Thoracic Surgery Authors: Preventza, O., Garcia, A., Tuluca, A., Henry, M., Cooley, D. A., Simpson, K., Bakaeen, F. G., Cornwell, L. D., Omer, S., Coselli, J. S. Tags: Pericardium AORTIC SURGERY Source Type: research

Surgical Treatment for Thrombus Straddling a Patent Foramen Ovale
We present a case of a 41-year-old female with deep vein thrombosis after abdominal surgery. The patient quickly developed severe pulmonary embolism and stroke representative of paradoxical embolism. Echocardiography showed a thrombus straddling a patent foramen ovale, which was confirmed intraoperatively. An accurate diagnosis and rapid treatment decisions are crucial for preventing patient deterioration in the form of new pulmonary embolisms or stroke.
Source: Revista Brasileira de Cirurgia Cardiovascular - December 12, 2016 Category: Cardiovascular & Thoracic Surgery Source Type: research

PFO closure: End of an era or beginning of a new chapter?
Key Points This large long‐term retrospective cohort study shows that percutaneous patent foramen ovale (PFO) closure is safe. Higher rates of recurrent stroke or TIA were noted in older patients (age>55) and those with diabetes and hypertension Randomized trials have failed to show significant benefit from PFO closure for cryptogenic stroke though pooled analyses and longer‐term follow‐up have revealed significant reduction in recurrent strokes. Future studies and longer‐term follow‐up will need to elucidate which subgroups of patients will benefit from closure.
Source: Catheterization and Cardiovascular Interventions - January 23, 2017 Category: Cardiovascular & Thoracic Surgery Authors: Mahmoud I. Traina, E. Murat Tuzcu Tags: Editorial Comment Source Type: research

Patent foramen ovale (PFO) closure versus medical therapy for prevention of recurrent stroke in patients with prior cryptogenic stroke: A systematic review and meta ‐analysis of randomized controlled trials
Catheterization and Cardiovascular Interventions, EarlyView.
Source: Catheterization and Cardiovascular Interventions - March 30, 2018 Category: Cardiovascular & Thoracic Surgery Source Type: research

Left atrial appendage occlusion
EuroIntervention. 2023 Feb 6;18(13):e1038-e1065. doi: 10.4244/EIJ-D-22-00627.ABSTRACTPrevention of stroke represents a goal of primary importance in health systems due to its associated morbidity and mortality. As several patient groups with increased stroke rates have been identified, multiple approaches have been developed and implemented: oral anticoagulation (OAC) for patients with atrial fibrillation, surgical and percutaneous revascularisation in patients with carotid disease, device closure for patients with patent foramen ovale, and now, left atrial appendage occlusion (LAAO) for selected patients with non-valvular...
Source: EuroIntervention - February 10, 2023 Category: Cardiovascular & Thoracic Surgery Authors: David R Holmes Kasper Korsholm Josep Rod és-Cabau Jacqueline Saw Sergio Berti Mohamad A Alkhouli Source Type: research

Pages: 1  2  3  4  5  6  7